(Total Views: 240)
Posted On: 01/05/2021 9:06:57 PM
Post# of 36568
So, how does this affect the deal with the Chinese?
Olaregen Therapeutix Inc. acquired the intellectual properties and global rights of Excellagen except in China, Russia and CIS, from Taxus Cardium, Inc., and its wholly owned subsidiaries Activation Therapeutics, Inc. and Gene Biotherapeutics, Inc.
Read More: https://investorshangout.com/post/view?id=600...z6ijHaTyku
Olaregen Therapeutix Inc. acquired the intellectual properties and global rights of Excellagen except in China, Russia and CIS, from Taxus Cardium, Inc., and its wholly owned subsidiaries Activation Therapeutics, Inc. and Gene Biotherapeutics, Inc.
Read More: https://investorshangout.com/post/view?id=600...z6ijHaTyku
(1)
(0)
